Unaudited Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2022		Dec. 31, 2021
Current Assets
Cash and cash equivalents	$ 783		$ 536
Trade receivables - third party and affiliates	1,317		1,161
Non-trade receivables, net	510		506
Inventories	1,713		1,524
Marketable securities	7		10
Other assets	129		70
Total current assets	4,459		3,807
Investments in affiliates	935		823
Property, plant and equipment (net of accumulated depreciation - 2022: $3,497; 2021: $3,484)	4,158		4,193
Operating Lease, Right-of-Use Asset	264		236
Deferred income taxes	232		248
Other assets	642		521
Goodwill	1,348	[1]	1,412
Intangible assets, net	675		735
Total assets	12,713		11,975
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates	809		791
Trade payables - third party and affiliates	1,250		1,160
Other liabilities	419		473
Income taxes payable	117		81
Total current liabilities	2,595		2,505
Long-term debt, net of unamortized deferred financing costs	3,022		3,176
Deferred income taxes	589		555
Uncertain tax positions	285		280
Benefit obligations	514		558
Operating lease liabilities	220		200
Other liabilities	263		164
Commitments and Contingencies
Stockholders' Equity
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2022 and 2021: 0 issued and outstanding)	0		0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2022: 170,050,081 issued and 108,346,035 outstanding; 2021: 169,760,024 issued and 108,023,735 outstanding)	0		0
Treasury stock, at cost (2022: 61,704,046 shares; 2021: 61,736,289 shares)	(5,492)		(5,492)
Additional paid-in capital	344		333
Retained earnings	10,466		9,677
Accumulated other comprehensive income (loss), net	(438)		(329)
Total Celanese Corporation stockholders' equity	4,880		4,189
Noncontrolling interests	345		348
Total equity	5,225		4,537
Total liabilities and equity	$ 12,713		$ 11,975

[1] There were no accumulated impairment losses as of June 30, 2022.